Aktie A3DWPS KALA BIO, INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen KALA BIO, Inc.

Aktien

A3DWPS

US4831192020

KALA

Markt geschlossen - Nasdaq
Andere Börsenplätze
 22:30:00 30.04.2024 		% 5 Tage % 1. Jan.
6.82 USD -0.44% Intraday Chart für KALA BIO, Inc. +3.87% -2.57%
02.04. KALA BIO, INC. : HC Wainwright bleibt bei seiner Kaufempfehlung ZM
29.03. KALA BIO, Inc. meldet Ergebnis für das am 31. Dezember 2023 endende Geschäftsjahr CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
KALA BIO, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
KALA BIO, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
KALA BIO, Inc. announced that it expects to receive $8.599799 million in funding from Baker Bros. Advisors LP
North American Morning Briefing : Stocks Struggle After New Records
North American Morning Briefing : Inflation -2-
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KALA BIO, Inc. announced that it expects to receive $1.999824 million in funding
KALA BIO, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
KALA BIO Reports Inducement Grants under Nasdaq Listing Rule 5635(4)
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
KALA BIO, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Kala Pharmaceuticals : Certificate of Incorporation/Bylaws - Form 8-K
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A3DWPS Aktie
  4. Nachrichten KALA BIO, Inc.
  5. Andere Sprachen